measuregroup/AID105451

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103394776_AID105451_PMID7086837_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103395272_AID105451_PMID7086837_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103395300_AID105451_PMID7086837_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103395302_AID105451_PMID7086837_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103507642_AID105451_PMID7086837_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID101497
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	In vitro antitumor activity (tumor cell growth inhibition) against MDAY-D2 cells
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103395302 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103395272 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103395300 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103507642 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103394776
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID105451

Total number of triples: 15.